(Sharecast News) - Belluscura's share price plummeted by a quarter on Friday after the medical device group said it was conducting a strategic review to "substantially strengthen its capital position".
The company, which develops oxygen enrichment technology spanning broad industries and therapies, said it experienced challenges in late February and March...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE